Sabra Health Care REIT, Inc.
SBRA · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.26 | -1.72 | 0.41 | 1.22 |
| FCF Yield | 1.84% | 1.93% | 1.95% | 2.24% |
| EV / EBITDA | 44.13 | 52.96 | 51.77 | 66.81 |
| Quality | ||||
| ROIC | 25.98% | 39.16% | 1.31% | -4.20% |
| Gross Margin | 67.70% | 67.35% | 67.18% | 72.76% |
| Cash Conversion Ratio | 4.44 | 1.24 | 1.99 | 1.71 |
| Growth | ||||
| Revenue 3-Year CAGR | 9.55% | 10.62% | 10.45% | 9.75% |
| Free Cash Flow Growth | 0.87% | 0.37% | -18.11% | 21.87% |
| Safety | ||||
| Net Debt / EBITDA | 12.14 | 15.62 | 19.04 | 23.95 |
| Interest Coverage | 2.61 | 0.00 | 2.40 | 2.19 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 73.76 | 61.97 | 253.31 | 61.41 |